Literature DB >> 23712184

Lung cancer: ALK status of NSCLC reflected in CTCs.

Vanessa Marchesi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23712184     DOI： 10.1038/nrclinonc.2013.89

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer.

Authors:  Emma Pailler; Julien Adam; Amélie Barthélémy; Marianne Oulhen; Nathalie Auger; Alexander Valent; Isabelle Borget; David Planchard; Melissa Taylor; Fabrice André; Jean Charles Soria; Philippe Vielh; Benjamin Besse; Françoise Farace
Journal:  J Clin Oncol       Date:  2013-05-13       Impact factor: 44.544
  1 in total
  1 in total

1.  Clinical potential of gene mutations in lung cancer.

Authors:  Miranda B Carper; Pier Paolo Claudio
Journal:  Clin Transl Med       Date:  2015-11-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.